case_images: PMC11807935_01
case_images: Patient 1: Before PRP injection, facial vascular dilation was found. (b) Patient 1: 1 month after one round of PRP injection, this patient's facial erythema significantly improved. (c) Patient 2: Before treatment, with bilateral cheek vascular dilation. (d) Patient 2: 1 month after three rounds of PRP injections and two sessions of delicate pulsed light (DPL) therapy, this patient showed considerable improvement. (e) Patient 3: Before treatment, with obvious papules and pustules. (f) Patient 3: 6 months after three rounds of PRP injections, the patient's inflammatory lesions exhibited a notable reduction without inducing systemic side effects, and there was no recurrence for 6 months.
case_images: JOCD-24-e70031-g001.jpg
case_images: PMC11807935_03_JOCD-24-e70031-g001.jpg
case_images: jocd70031-fig-0001
case_images: This case demonstrated the role of PRP in reducing inflammatory lesions without the use of systemic medications (Figure 1e,f).
case_images: PMC11807935_02
case_images: Patient 1: Before PRP injection, facial vascular dilation was found. (b) Patient 1: 1 month after one round of PRP injection, this patient's facial erythema significantly improved. (c) Patient 2: Before treatment, with bilateral cheek vascular dilation. (d) Patient 2: 1 month after three rounds of PRP injections and two sessions of delicate pulsed light (DPL) therapy, this patient showed considerable improvement. (e) Patient 3: Before treatment, with obvious papules and pustules. (f) Patient 3: 6 months after three rounds of PRP injections, the patient's inflammatory lesions exhibited a notable reduction without inducing systemic side effects, and there was no recurrence for 6 months.
case_images: JOCD-24-e70031-g001.jpg
case_images: PMC11807935_03_JOCD-24-e70031-g001.jpg
case_images: jocd70031-fig-0001
case_images: This case demonstrated the role of PRP in reducing inflammatory lesions without the use of systemic medications (Figure 1e,f).
case_images: PMC11807935_03
case_images: Patient 1: Before PRP injection, facial vascular dilation was found. (b) Patient 1: 1 month after one round of PRP injection, this patient's facial erythema significantly improved. (c) Patient 2: Before treatment, with bilateral cheek vascular dilation. (d) Patient 2: 1 month after three rounds of PRP injections and two sessions of delicate pulsed light (DPL) therapy, this patient showed considerable improvement. (e) Patient 3: Before treatment, with obvious papules and pustules. (f) Patient 3: 6 months after three rounds of PRP injections, the patient's inflammatory lesions exhibited a notable reduction without inducing systemic side effects, and there was no recurrence for 6 months.
case_images: JOCD-24-e70031-g001.jpg
case_images: PMC11807935_03_JOCD-24-e70031-g001.jpg
case_images: jocd70031-fig-0001
case_images: This case demonstrated the role of PRP in reducing inflammatory lesions without the use of systemic medications (Figure 1e,f).
case_images: PMC11807935_04
case_images: (a) Patient 4: Before treatment, with recurrent facial erythema, papules, and pustules, (b) Patient 4: 1 month after one round of PRP combined with botulinum toxin injection and two rounds of photon therapy. She showed remarkable improvement with no recurrence. (c) Patient 5: Before PRP injection, with distinct facial and perioral erythema, papules, and pustules. (d) Patient 5: 2 months after two rounds of PRP injection. no medication was taken, her rash significantly improved and did not recur.
case_images: JOCD-24-e70031-g002.jpg
case_images: PMC11807935_05_JOCD-24-e70031-g002.jpg
case_images: jocd70031-fig-0002
case_images: This case highlights the potential of PRP in the management of refractory cases of rosacea (Figure 2c,d).
case_images: PMC11807935_05
case_images: (a) Patient 4: Before treatment, with recurrent facial erythema, papules, and pustules, (b) Patient 4: 1 month after one round of PRP combined with botulinum toxin injection and two rounds of photon therapy. She showed remarkable improvement with no recurrence. (c) Patient 5: Before PRP injection, with distinct facial and perioral erythema, papules, and pustules. (d) Patient 5: 2 months after two rounds of PRP injection. no medication was taken, her rash significantly improved and did not recur.
case_images: JOCD-24-e70031-g002.jpg
case_images: PMC11807935_05_JOCD-24-e70031-g002.jpg
case_images: jocd70031-fig-0002
case_images: This case highlights the potential of PRP in the management of refractory cases of rosacea (Figure 2c,d).